NCT06303193
- Conditions
- Anemia, Anemia, Aplastic, Anemia, Refractory, +7 more
- Locations
-
- National Institutes of Health Clinical Center Bethesda, Maryland, United States
Clinical trial condition
Hemic and Lymphatic Diseases
Explore clinical trials studying Hemic and Lymphatic Diseases. Study availability and eligibility vary by location and protocol.
21,072 public trials
3,987 recruiting studies
Hemic and Lymphatic Diseases trial results
NCT07027826
- Conditions
- Deglutition Disorders, Digestive System Diseases, Dysphagia, +14 more
- Locations
-
- National Institutes of Health Clinical Center Bethesda, Maryland, United States
- Gabriel Toure University Hospital Center Bamako, Mali
- Mali International Center for Excellence in Research Bamako, Mali
Recruiting
HEARTS Trial for Thoracic Cancers
NCT07132918
- Conditions
- Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +25 more
- Locations
-
- University of Wisconsin - Madison Madison, Wisconsin, United States
Recruiting
Tocilizumab for Acute Chest Syndrome
NCT05640271
- Conditions
- Acute Chest Syndrome, Anemia, Anemia, Hemolytic, +11 more
- Locations
-
- University of Chicago Chicago, Illinois, United States
NCT03816345
- Conditions
- Arthritis, Arthritis, Psoriatic, Arthritis, Rheumatoid, +59 more
- Locations
-
- University of Alabama at Birmingham Cancer Center Birmingham, Alabama, United States
- Stanford Cancer Institute Palo Alto Palo Alto, California, United States
- University of California Davis Comprehensive Cancer Center Sacramento, California, United States
- Smilow Cancer Center/Yale-New Haven Hospital New Haven, Connecticut, United States
Recruiting
Safety and Efficacy of RVU120 Combined With Venetoclax for Treatment of Relapsed/Refractory AML
NCT06191263
- Conditions
- Acute Myeloid Leukemia, Hematologic Diseases, Hemic and Lymphatic Diseases, +5 more
- Locations
-
- Centre Hospitalier Universitaire Grenoble Alpes Grenoble, France
- Centre Hospitalier Le Mans Le Mans, France
- Centre Hospitalier Universitaire De Lille Lille, France
- Institut Paoli-Calmettes Marseille, France
Recruiting
MEN1703 (SEL24) to Treat Relapsed or Refractory Aggressive B-cell Non-Hodgkin Lymphoma (JASPIS-01)
NCT06534437
- Conditions
- Aberrant Motor Behavior in Dementia, Aggression, Behavior, +16 more
- Locations
-
- Centre Hospitalier Le Mans Le Mans, France
- CHU de Lille - Hôpital Claude Huriez Lille, France
- CHU de Limoges - CHU Dupuytren Limoges, France
- Hospices Civils De Lyon - Hôpital Lyon Sud Lyon, France
Recruiting
Study of IgPro20 to Prevent Infection in People With Multiple Myeloma and Hypogammaglobulinemia
NCT06976476
- Conditions
- Agammaglobulinemia, Blood Protein Disorders, Cardiovascular Diseases, +18 more
- Locations
-
- Memorial Sloan Kettering Basking Ridge (All Protocol Activities) Basking Ridge, New Jersey, United States
- Memorial Sloan Kettering Monmouth (All Protocol Activities) Middletown, New Jersey, United States
- Memorial Sloan Kettering Bergen (All Protocol Activities) Montvale, New Jersey, United States
- Memorial Sloan Kettering Suffolk-Commack (All Protocol Activity) Commack, New York, United States
NCT04996875
- Conditions
- Advanced Systemic Mastocytosis (AdvSM), Aggressive Systemic Mastocytosis (ASM), Bone Marrow Diseases, +35 more
- Locations
-
- University of Alabama at Birmingham (UAB) Hospital Birmingham, Alabama, United States
- Mayo Clinic Arizona Phoenix, Arizona, United States
- City of Hope Comprehensive Cancer Center Duarte, California, United States
- UCLA Medical Center Los Angeles, California, United States
NCT04840602
- Conditions
- Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +18 more
- Locations
-
- Banner University Medical Center - Tucson Tucson, Arizona, United States
- University of Arizona Cancer Center-North Campus Tucson, Arizona, United States
- City of Hope at Irvine Lennar Irvine, California, United States
- UM Sylvester Comprehensive Cancer Center at Coral Gables Coral Gables, Florida, United States